FUSED IMIDAZOLES FOR CANCER TREATMENT

Compounds of Formula (I), a tautomer or stereoisomer thereof, or a salt thereof,wherein ring B and the imidazole to which it is fused, R4, R6 and R7 have the meanings as given in the description and the claims, are effective inhibi tors of the Pi3K/Akt pathway.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MAIER THOMAS, PATEL SARVESH A, GORE VIKAS, CHAVAN SUNIL, GEKELER VOLKER, ZUELCH ARMIN, JOSHI HEMANT, BHISE UMESH, MUNOT YOGESH S, SHIVATARE SACHIN S, ZIMMERMANN ASTRID, BECKERS THOMAS, BAER THOMAS, HOELDER SWEN
Format:	Patent
Sprache:	eng ; kor
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Compounds of Formula (I), a tautomer or stereoisomer thereof, or a salt thereof,wherein ring B and the imidazole to which it is fused, R4, R6 and R7 have the meanings as given in the description and the claims, are effective inhibi tors of the Pi3K/Akt pathway.